|
Registry of Asthma Characterization and Recruitment 3 (RACR3)
RECRUITINGSponsored by National Institute of Allergy and Infectious Diseases (NIAID)
Actively Recruiting
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Started2022-04-15
Est. completion2028-05
Eligibility
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT05272241
Summary
This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
Eligibility
Healthy volunteers accepted
Inclusion Criteria: 1. Participant is either: 1. At least 18 years old, willing and able to provide informed consent at the time of enrollment 2. Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment 2. Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA) Exclusion Criteria: 1. Participant does not speak English or Spanish and/or guardian does not speak English or Spanish 2. Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up 3. Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy. Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.
Conditions1
Asthma
Locations7 sites
Children's Hospital Colorado: Allergy Program
Aurora, Colorado, 80045
Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site
Washington D.C., District of Columbia, 20010
Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology
Chicago, Illinois, 60611
Boston Children's Hospital: Department of Immunology
Boston, Massachusetts, 02215
617-919-1301
Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute
New York, New York, 10029
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorNational Institute of Allergy and Infectious Diseases (NIAID)
Started2022-04-15
Est. completion2028-05
Eligibility
Healthy vol.Accepted
Locations7 sites
View on ClinicalTrials.gov →
NCT05272241